Abstract
Recent exceptional growth in human exposure to natural products known to originate from traditional medicine has lead to a resurgence of scientific interest in their biological effects. As a strategy for improvement of the assessment of their pharmacological and toxicological profile, scientific evidence-based approaches are being employed to appropriately evaluate composition, quality, potential medicinal activity and safety of these natural products. Using this approach, we comprehensively reviewed existing scientific evidence for known composition, medicinal uses (past and present), and documented biological effects with emphasis on clinical pharmacology and toxicology of two commonly used medicinal plants from South America with substantial human exposure from historical and current global use: Uncaria tomentosa (common name: cat’s claw, and Spanish: uña de gato), and Lepidium meyenii (common name: maca). Despite the geographic sourcing from remote regions of the tropical Amazon and high altitude Andean mountains, cat’s claw and maca are widely available commercially in industrialised countries. Analytical characterisations of their active constituents have identified a variety of classes of compounds of toxicological, pharmacological and even nutritional interest including oxindole and indole alkaloids, flavonoids, glucosinolates, sterols, polyunsaturated fatty acids, carbolines and other compounds.
The oxindole alkaloids from the root bark of cat’s claw are thought to invoke its most widely sought-after medicinal effects as a herbal remedy against inflammation. We find the scientific evidence supporting this claim is not conclusive and although there exists a base of information addressing this medicinal use, it is limited in scope with some evidence accumulated from in vitro studies towards understanding possible mechanisms of action by specific oxindole alkaloids through inhibition of nuclear factor (NF)-κB activation. Although controlled clinical studies have demonstrated reduction in pain associated with cat’s claw intake in patients with various chronic inflammatory disorders, there is insufficient clinical data overall to draw a firm conclusion for its anti-inflammatory effects. An important observation was that experimental results were often dependent upon the nature of the preparation used. It appears that the presence of unknown substances has an important role in the overall effects of cat’s claw extracts is an important factor for consideration. The available animal toxicological studies did not indicate severe toxicity from oral intake of cat’s claw preparations but rather were suggestive of a low potential for acute and subacute oral toxicity, and a lack of evidence to demonstrate genotoxic potential and mutagenic activity.
Maca is a clear example of a herb with substantial medicinal use in traditional herbal medicine by indigenous cultures in South America since the first recorded knowledge of it in the seventeenth century. The hypocotyls of maca are the edible part of the plant used for nutritional and proposed fertility-enhancing properties. Maca has been described to possess many other medicinal properties in traditional herbal medicine but only a few of them have been well studied scientifically. Published clinical studies of maca seem to be related to its property as a nutrient, for male fertility and for energy. There are inadequate data regarding the precise mechanism of action of maca. Some studies suggest that secondary metabolites found in maca extracts are important constituents responsible for its physiological effects. Maca has been reported in the scientific literature to have a low degree of acute oral toxicity in animals and low cellular toxicity in vitro.
An important finding unveiled by this review is the importance of standardisation in quality and additional basic and clinical research to scientifically validate and understand composition, biological activity, safety and risk. Development of a comprehensive pharmacological and toxicological profile through critical evaluation of existing and future experimental data, especially carefully conducted clinical studies would facilitate the scientific evidence-based approach to understanding potential biological effects of these major traditionally based herbals in current global use.
Similar content being viewed by others
Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Dev S. Ethnotherapeutics and modern drag development: the potential of Ayurveda. Curr Sci 1997; 73: 909–28
Dev S. Ancient-modern concordance in Ayurvedic plants: some examples. Environ Health Perspect 1999; 107: 783–9
Barnes P, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States, 2002. Hyattsville (MD): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2004 May. Advance data report no. 343
Mahady, Gail B, Fong HS, et al., editors. Botanical dietary supplements: quality, safety and efficacy. Lisse: Swets & Zeitlinger, 2001
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75
Committee on the Framework for Evaluating Safety of Dietary Supplements Food and Nutrition Board on Life Sciences, Institute of Medicine and National Research Council of the National Academies. Scientific principals for integrating and evaluating the available data. In: Dietary supplements: a framework for evaluating safety. Washington, DC: The National Academies Press, 2004: 1–13
Desmarchelier C, Schaus FW. Sixty medicinal plants from the Peruvian amazon: ecology, ethnomedicine and bioactivity. 1st ed. Lima: Bio2000, 2000
Mulry M. Review of the First International Conference on St John’s wort. Herbal-Gram 1999; 45: 61–5
Keplinger K, Laus G, Wurm M, et al. Uncaria tomentosa (Willd.) DC-ethnomedicinal use and new pharmacological, toxicological and botanical results. J Ethnopharmacol 1999; 64: 23–4
Williams JE. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on uña de gato and sangre de grado. Altem Med Rev 2001; 6: 567–79
Reinhard KH. Uncaria tomentosa (Willd.) D.C.: cat’s claw, uña de gato, or savéntaro. J Altern Complement Med 1999; 2: 143–51
Hammond G, Fernández ID, Villegas LF, et al. A survey of traditional medicinal plants from the Callejón de Huaylas, Department of Ancash, Peru. J Ethnopharmacol 1998; 61: 17–30
Villegas LF, Fernández ID, Maldonado H, et al. Evaluation of the wound-healing activity of selected traditional medicinal plants from Peru. J Ethnopharmacol 1997; 55: 193–200
Fong HHS. Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 2002; 1: 287–93
World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans: some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Vol. 82. Lyon: IARC Press, 2002
Taylor L. Herbal secrets of the rainforest: technical data report for cat’s claw ‘uña de gato’ (Uncaria tomentosa). 2nd ed. Austin (TX): Sage Press Inc., 2002
Duke J, Vasquez R. Amazonian ethobotanical dictionary. Boca Raton (FL): CRC Press, 1994
Piscoya J, Rodriguez Z, Bustamante SA, et al. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflamm Res 2001; 50: 442–8
Gattuso M, Di Sapio O, Gattuso S, et al. Morphoanatomical studies of Uncaria tomentosa and Uncaria guianensis bark and leaves. Phytomedicine 2004; 11: 213–23
Foster BC, Vandenhoek S, Hana J, et al. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 2003; 10: 334–42
Laus G, Keplinger K. Radix Uncarie tomentosae (Wild.) DC. Z Phytother 1997; 18: 122–6
Jones K. The herb report: uña de gato, life-giving vine of Peru. Am Herb Assoc 1994; 10: 4
The review of natural products by facts and comparisons. St Louis (MO): Wolters Kluwer Co., 1999
Beckstrom-Sternberg S, Duke J, Wain K. Chemicals in Uncaria tomentosa DC (Pedaliaceae): the ethnobotany database. Fulton (MD): Agricultural Research Service, 1996
Heitzman ME, Neto CC, Winiarz E, et al. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochem 2005; 66: 5–29
Montoro P, Carbone V, Quiroz Jde D, et al. Identification and quantification of components in extracts of Uncaria tomentosa by HPLC-ES/MS. Phytochem Anal 2004; 15: 55–64
Aquino R, De Feo V, De Simone F, et al. Plant metabolites: new compounds and anti-inflammatory activity of Uncaria tomentosa. J Nat Prod 1991; 54: 433–59
Laus G, Brössner D, Keplinger K. Alkaloids of Peruvian Uncaria tomentosa. Phytochemistry 1997; 45: 855–60
Hemingway SR, Phillipson JD. Alkaloids from S. American species of Uncaria (Rubiaceae) [abstract]. J Pharm Pharmacol 1974; 26 Suppl.: 113P
Stuppner H, Sturm S. Capillary electrophoretic analysis of oxindole alkaloids from Uncaria tomentosa. J Chromatogr 1992; 609: 375–80
Ganzera M, Muhammad I, Khan RA, et al. Improved method for the determination of oxindole alkaloids in Uncaria tomentosa by high performance liquid chromatography. Planta Med 2001; 67: 447–50
Stuppner H, Sturm S, Konwalinka G. HPLC analysis of the main oxindole alkaloids from Uncaria tomentosa. Chromatographia 1992; 34: 597–00
Kitajima M, Hashimoto K, Yokoya M, et al. A new gluco indole alkaloid, 3, 4-dehydro-5-carboxystrictosidine, from Peruvian una de gato (Uncaria tomentosa). Chem Pharm Bull (Tokyo) 2000; 48: 1410–2
Muhammad I, Dunbar D, Khan R, et al. Investigation on uña de gato I. 7-deoxyloganic acid and 15N NMR spectroscopic studies on pentacyclic oxindole alkaloids from Uncaria tomentosa. Phytochemistry 2001; 57: 781–5
Aquino R, Conti C, Stein ML. Plant metabolites: structure and in vitro antiviral activity of quinovic acids glycosides from Uncaria tomentosa and Guettarda platypoda. J Nat Prod 1989; 52: 679–85
Aquino R, De Tommasi N, De Simone F, et al. Triterpenes and quinovic acid glycosides from Uncaria tomentosa. Phytochemistry 1997; 45: 1035–40
Cerri R, Aquino R, De Simone F, et al. New quinovic acid glycosides from Uncaria tomentosa. J Nat Prod 1988; 51: 257–61
Yepez M, Lock de Ugaz O, Alvarez ACM, et al. Quinovic acid glycosides from Uncaria guianensis. Phytochemistry 1991; 30: 1635–7
Kitajima M, Yokoya M, Takayama H, et al. Two new nor-triterpene glycosides from Peruvian ‘uña de gato’ (Uncaria tomentosa). J Nat Prod 2003; 66: 320–3
Montenegro De Matta S, Delle Monache F, Ferrari F, et al. Alkaloid and procyanidins of an Uncaria sp. from Peru. II. Fármaco 1976; 31: 527–35
Aquino R, De Simone F, Vincieri F, et al. New polyhydroxylated triterpenes from Uncaria tomentosa. J Nat Prod 1990; 53: 559–64
Kitajima M, Hashimoto K, Yokoya M, et al. Two new 19-hydroxyursolic acid-type triterpenes from Peruvian ‘uña de gato’ (Uncaria tomentosa). Tetrahedron 2000; 56: 547–52
Wirth C, Wagner H. Pharmacologically active procyanidines from the bark of Uncaria tomentose. Phytomedicine 1997; 4: 265–7
Senatore A, Cataldo A, Laccarino FP, et al. Ricereche fitochjmjehe e biologiche sull Uncaria tomentosa. Boll Soc Ital Biol Sper 1989; 656: 517–20
Laus G, Keplinger K. Separation of steroisomeric oxindole alkaloids from Uncaria tomentosa by high performance liquid chromatography. J Chromatogr A 1997; 662: 243–9
Laus G, Brössner D, Senn G, et al. Analysis of the kinetics of isomerization of spiro oxindole alkaloids. J Chem Soc Perkin Trans 1996; 2: 1931–6
Laus G. Kinetics of isomerization of tetracyclic spiro oxindole alkaloids. J Chem Soc Perkin Trans 1998; 2: 315–7
Obregón Vilches L. Uña de gato. Género Uncaria, estudios botánicos, químicos y farmacológicos de Uncaria tomentosa y Uncaria guianensis. Lima (Perú): Institute de Fitoterapia Americano ed., 1997: 53–7
Mur E, Hartig F, Eibl G, et al. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemo-type of Uncaria tomentosa for the treatment of rheumatoid arthritis. J Rheumatol 2002; 29: 678–81
Wolters Kluwer Health Inc. eFacts: review of natural products. Facts and comparisions. Cat’s claw [online]. Available from URL: http://www.efactsweb.com/RNP/RNPMonoDetail.asp?.itemID =61063&optIndexID=61064 [Accessed 2004 Sep 1]
Schauss AG. Cat’s claw (Uncaria tomentosa). Nat Med J 1998; 1: 16–9
Gruenwalk J, Brendler T, Jaenicke C, editors. PDR for herbal medicines. Montvale (NJ): Medical Economics Company Inc., 2000
Sheng Y, Bryngelsson C, Pero RW. Enhanced DNA repair, immune function and reduced toxicity of C-MED100™, a novel aqueous extract from Uncaria tomentosa. J Ethnopharmacol 1999; 69: 115–26
Sheng Y, Li L, Holmgren K, et al. DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. Phytomedicine 2001; 8: 275–82
Leon FR, Ortiz N, Antunez de Mayolo A, et al. Antimutagenic activity of a freeze-dried aqueous extract of Uncaria tomentosa in smokers and non-smokers. Third European Colloquium on Ethnopharmacology; 1996 May 29–Jun 2; Genova (Italy): European colloquim on Ethnopharmacology, 1996: 255
Rizzi R, Re F, Bianchi A, et al. Mutagenic and antimutagenic activities of Uncaria tomentosa and its extracts. J Ethnopharmacol 1993; 38: 63–7
Hilepo JN, Bellucci AG, Mossey RT. Acute rental failure caused by ‘cat’s claw’ herbal remedy in a patient with systemic lupus erythematosus [letter]. Nephron 1997; 77: 361–9
Budzinski JW, Foster BC, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7: 273–82
Hammerly M, Murray MT, Spoerke DG. Micromedex systems. AltMedex. Cat’s claw [online]. Available from URL: http://csi.micromedex.com/DKS/DATA/AL/AL0069.HTM?.Top=Yes [Accessed 2005 Jan 13]
Natural Medicines Comprehensive Database. 2004. ‘Maca’ [online]. Available from URL: http://www.naturaldatabase.com/monograph.asp?.mono_id=555&brand_id= [Accessed 2004 Apr 20]
McGuffin M, Hobbs C, Upton R, et al. editors. American Herbal Products Association’s Botanical Safety Handbook. Boca Raton (FL): CRC Press, 1997
Kynoch SR, Lloyd GK. Acute oral toxicity to mice of substance E-2919. Huntington (England): Huntington Research Centre, 1975. (Data on file)
Kreutzkamp B. Niedermolekulare Inhaltsstoffe mit immunstimulierenden Eigenschaften aus Uncaria tomentosa and Okoubaka aubrevillei und anderen Drogen [dissertation]. Munich: University of Munich, 1984
Svendsen O, Skydsgaard K. Test report (Extraction radicis Uncariae tomentosae). Denmark: Scantox Biological Laboratory Ltd, 1986. (Data on file)
Sheng Y, Pero RW, Wagner H. Treatment of chemotherapy-induced leukopenia in a rat model with aqueous extract from Uncaria tomentosa. Phytomedicine 2000; 7: 137–43
Aguilar J, Rojas P, Marcelo A, et al. Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiacea). J Ethnopharmacol 2002; 81: 271–6
Sandoval-Chacon M, Thompson JH, Zhang XJ, et al. Antiinflammatory actions of cat’s claw: the role of NF-kappaB. Alimentary Pharmacol Ther 1998; 12: 1279–89
Cisneros FJ, Jayo M, Niedziela L. An Uncaria tomentosa (cat’s claw) extract protects mice against ozone-induced lung inflammation. J Ethnopharmacol 2005; 96: 355–64
Mestanza D. Evalución de la actividad immunoestimulante de Uncaria tomentosa (Willd.) DC. uña de gato en ratones albinos. Bioversidad Salud 1999; 1: 16–9
Santa Maria A, Lopez A, Diaz MM, et al. Evaluation of the toxicity of Uncaria tomentosa by bioassays in vitro. J Ethnopharmacol 1997; 57: 183–7
Sandoval M, Charbonnet RM, Okuhama NN, et al. Cat’s claw inhibits TNFα production and scavenges free radicals: role in cytoprotection. Free Radic Biol Med 2000; 29: 71–8
Desmarchelier C, Mongelli E, Coussio J, et al. Evaluation of the in vitro antioxidant activity in extracts of Uncaria tomentosa (Willd.) DC. Phytother Res 1997; 11: 254–6
Miller MJ, Angeles FM, Reuter BK, et al. Dietary antioxidants protect gut epithelial cells from oxidant-induced apoptosis. BMC Complement Altern Med 2001; 1: 1–10
Sandoval M, Ronzio RA, Mwanza DN, et al. Protection from peroxynitrite-induced apoptosis by plant-derived antioxidants [abstract]. FASEB J 1997; 11: A648
Riva L, Cordini D, Di Frunzo G, et al. The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Res 2001; 21: 2457–61
Stuppner H, Sturm S, Geisen G, et al. A differential sensitivity of oxindole alkaloids to normal and leukemic cell lines. Planta Med 1993; 59Suppl. A: 583
Sheng Y, Pero RW, Amiri A. Induction of apoptosis and inhibition of proliferation in human tumor cells treated with extracts of Uncaria tomentosa. Anticancer Res 1998; 18: 3363–8
Akesson CH, Pero RW, Ivars F. C-Med 100, a hot water extract of Uncaria tomentosa, prolongs lymphocyte survival in vivo. Phytomedicine 2003; 10: 23–33
Wagner H, Kreutzkamp B, Jurcic K. Die Alkaloide von Uncaria tomentosa und ihre Phagozytose-steigernde Wirkung. Planta Med 1985; 5: 419–23
Wurm M, Kacani L, Laus G, et al. Pentacyclic oxindole alkaloids from Uncaria tomentosa induce human endothelial cells to release a lymphocyte-proliferation-regulating factor. Planta Med 1998; 64: 701–4
Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141–79
Bernard P, Scior T, Didier B, et al. Ethnopharmacology and bioinformatics combination for leads discovery: application to phospholipase A2 inhibitors. Phytochemistry 2001; 58: 865–74
Sandoval M, Okuhama NN, Zhang XJ, et al. Anti-inflammatory and antioxidant activities of cat’s claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 2002; 9: 325–37
Lemaire I, Assinewe V, Cano P, et al. Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (una de gato). J Ethnopharmacol 1999; 64: 109–15
Keplinger K, Wagner H, Kreutzkamp B. Oxindole alkaloids having properties stimulating the immunological system. US Patents 4,244,901, 1989
Keplinger K, Wagner H, Kreutzkamp B. Oxindole alkaloids having properties stimulating the immunological system. US patents 4,940,425, 1990
Cieza de Leon P. Chronicle of Peru. First part 1553; 240: 354
Cobo B. History of the new world. Madrid: Biblioteca de autores españoles, 1956: 1–430
Quiroz C, Aliaga R. Maca (Lepidium meyenii Walp.) Andean roots and tubers: ahipa, arracacha, maca and yacon. In: Hermann M, Hellers J, editors. Promoting the conservation and use of underutilized neglected crops. Rome: International Plant Genetic Resources Institute, 1997; 21: 173–97
Tello J, Hermann M, Calderon A. La maca (Lepidium meyenii Walp.) cultivo alimenticio potencial para las zonas andinas. Boletín Lima 1992; 14: 59–66
National Research Council. Lost crops of the Incas: little-known plants of the Andes with promise for worldwide cultivation. Washington, DC: The National Academies Press, 1989: 56–65
Balick MJ, Lee R. Maca: from traditional food crop to energy and libido stimulant. Altern Ther Health Med 2002; 8: 96–8
Toledo J, Dehal P, Jarrin F, et al. Genetic variability of Lepidium meyenii and other Lepidium species (Brassicaceae) assessed by molecular markers. Ann Bot (Lond) 1998; 82: 523–30
Bracko L, Zarucchi J. Catalogue of the flowering plants and gymnosperms of Peru. In: monographs in systematic botany. New York: Missouri Botanical Garden 1993; 45: 1–1286
Quiroz CF, Epperson A, Hu J, et al. Physiological and cytological characterization of maca, Lepidium meyenii Walp. Econ Bot 1996; 50: 216–23
Yllescas M. Chemical and physicochemical study of three ecotypes of Lepidium meyenii from Carhuamayo [dissertation]. Lima: Faculty of Pharmacy and Biochemistry. Universidad Nacional Mayor de San Marcos, 1994
Bianchi A. Maca Lepidium meyenii. Boletin Latino americano y del caribe de plantas medicinales y aromáticas 2003; 2: 30–6
Piacente S, Carbone V, Plaza A, et al. Investigation of the tuber constituents of maca (Lepidium meyenii Walp). J Agric Food Chem 2002; 50: 5621–5
Carrillo F, Poma de Ayala G, editors. Cronistas Indios y Mestizos. Lima: Enciclopedia Histórica de la Literatura Peruana 7. Editorial Horizonte, 1992: 343
Rea J. Andean roots. In: Bermejo JEH, Leon J, editors. Neglected crops: 1492 from a different perspective. Plant production and protection series no. 26. Rome: Food and Agriculture Organization (FAO), 1994: 165–79
Dini A, Migliuolo G, Ratrelli L, et al. Chemical composition of Lepidium meyenii. Food Chem 1994; 49: 347–9
Li G, Ammermann U, Quiros CF. Glucosinolate contents in maca (Lepidium peruvianum Chacon) seeds, sprouts, mature plants and several derived commercial products. Econ Bot 2001; 55: 255–62
Baquerizo-Vasquez GL. Estudio quimico-bromatológico del Lepidium meyenii Walp. (maca) y el Aiphanes var. Deltoidea burret (Shica-shica) [dissertation]. Lima: Faculty of Medicine, Universidad Nacional Mayor de San Marcos, 1968
Espinoza CL, Poma IP. Determination de aminoácidos esenciales de la maca (Lepidium meyenii Walp.) y elaboración de una mezcla proteina a base de alimentos andinos [dissertation]. Huancayo (Peru): Faculty of Engineering in Alimentary Industries, Universidad Nacional del Centro del Peru, 1995
Chacón G. Phytochemical Studies of Lepidium meyenii Walp [dissertation in Spanish]. Lima: Universidad Nacional Mayor de San Marcos, 1961
Johns T. The anu and the maca. J Ethnobiol 1981; 1: 208–12
Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001; 56: 5–51
Zheng BL, He K, Kim CH, et al. Effect of a lipidic extract from Lepidium meyenii on sexual behavior in mice and rats. Urology 2000; 55: 598–602
Dini I, Tenore GC, Dini A. Glucosinolates from maca (Lepidium meyenii). Biochem Syst Ecol 2002; 30: 1087–90
Tellez MR, Khan IA, Kobaisy M, et al. Composition of the essential oil of Lepidium meyenii (Walp.). Phytochemistry 2002; 61: 149–55
Ciska E, Martyniak-Przybyszwska B, Kozlowska H. Content of glucosinolates in cruciferous vegetables grown at the same site for two years under different climatic conditions. J Agric Food Chem 2000; 48: 2862–7
Muhammad I, Zhao J, Dunbar DC. Constituents of Lepidium meyenii ‘maca’. Phytochemistry 2002; 59: 105–10
Ganzera M, Zhao J, Muhammad I, et al. Chemical profiling and standardization of Lepidium meyenii (maca) by reversed phase high performance liquid chromatography. Chem Pharm Bull (Tokyo) 2002; 50: 988–91
Jeri H. Estudio fitoqufmico de la maca [dissertation]. Pasco (Peru): Engineering Faculty. Universidad Nacional Daniel Alcides Carrion, 1990
Lee K-J, Dabrowski K, Rinchard J, et al. Supplementation of maca (Lepidium meyenii) tuber meal in diets improves growth rate and survival of rainbow trout Oncorhynchus mykiss (Walbaum) alevins and juveniles. Aquac Res 2004; 35: 215–23
Cui B, Zheng BL, He K, et al. Imidazole alkaloids from Lepidium meyenii. J Nat Prod 2003; 66: 1101–3
Ruiz H. Relación histórica del viaje a los reinos del Peru y Chile, 1777–1778. Madrid: Madrid Acad De Ciencias Exactas, Fis y Nat, 1952: 1–526
Aslam H, Rosiepen G, Krishnamurthy H, et al. The cycle duration of the seminiferous epithelium remains unaltered during GnRH antagonist-induced testicular involution in rats and monkeys. J Endocrinol 1999; 161: 281–8
Gonzales GF, Gasco M, Córdova A, et al. Effect of Lepidium meyenii (maca) on spermatogenesis in male rats acutely exposed to high altitude (4340 m). J Endocrinol 2004; 180: 87–95
Alvarez CJ. Utilización de diferentes niveles de maca en la fertilidad de cobayos [dissertation]. Pasco (Peru): Faculty of Agriculture and Cattle Sciences, Universidad Nacional Daniel Alcides Carrión, 1993
Willard T. Sowing your wild oats and reaping love’s benefits. Total Health 2000; 22: 62–3
Ahmed AJ. Maca-stimulin libido Redux. Total Health 2003; Suppl. 25: 15–6
Gonzales GF, Córdova A, Gonzales C, et al. Improved sperm count after administration of Lepidium meyenii (maca) in adult men. Asian J Androl 2001; 3: 301–4
Canales M, Aguilar J, Prada A, et al. Nutritional evaluation of Lepidium meyenii (maca) in albino mice and their descendants [in Spanish]. Arch Latinoam Nutr 2000; 50: 126–33
Cicero AF, Bandieri E, Arletti R. Lepidium meyenii Walp. improves sexual behaviour in male rats independently from its action on spontaneous locomotor activity. J Ethnopharmacol 2001; 75: 225–9
Cicero AF, Piacente S, Plaza A, et al. Hexanic maca extract improves rat sexual performance more effectively than methanolic and chloroformic maca extracts. Andrologia 2002; 34: 177–9
Gonzales GF, Córdova A, Vega K, et al. Effect of Lepidium meyenii (maca) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia 2002; 34: 367–72
Oshima M, Gu Y, Tsukada S. Effects of Lepidium meyenii Walp and Jatropha macrantha on blood levels of estradiol-17β, progesterone, testosterone and the rate of embryo implantation in mice. J Vet Med Sci 2003; 65: 1145–6
Gonzales GF, Ruiz A, Gonzales C. Effect of Lepidium meyenii (maca) roots on spermatogenesis of male rats. Asian J Androl 2001; 3: 231–3
Gonzales GF, Córdova A, Vega K, et al. Effect of Lepidium meyenii (maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J Endocrinol 2003; 176: 163–8
Gonzales GF, Rubio J, Chung A, et al. Effect of alcoholic extract of Lepidium meyenii (maca) on testicular function in male rats. Asian J Androl 2003; 5: 349–52
Zheng BH, He K, Hwang ZY, et al. Effect of aqueous extract from Lepidium meyenii on mouse behavior in forced swimming test. In: Quality management of nutraceuticals. ACS symposium series 803; 2002; 259–68; Washington, DC: American Chemical Society, 2002
Tapia A, López C, Marcelo A, et al. The maca (Lepidium meyenii) and their effect anti-stress in an animal model in mice [in Spanish]. Acta Andina 1999–2000; 8: 45–56
Sandoval M, Okuhama NN, Angeles FM, et al. Antioxidant activity of the cruciferous vegetable maca (Lepidium meyenii). Food Chem 2002; 79: 207–13
Park TH, Kwon OS, Park SY, et al. N-methylated beta-carbolines protect PC12 cells from cytotoxic effect of MTP+ by attenuation of mitochondrial membrane permeability change. Neurosci Res 2003; 46: 349–58
Marcelo A, Canales M, Aguilar J. Toxicity testing of maca. Lima: Instituto de Medicina Tropical Alexander von Humboldt, 2004. (Data on file)
Obregon L. Maca. Planta medicinal y nutritiva del Peru. 1st ed. Lima: Instituto de Fitoterapia Americana, 1998: 143–44
Blumenthal M, editor. The Complete German Commission E monographs: therapeutic guide to herbal medicines. Boston (MA): American Botanical Council, 1998: 12
Sparreboom A, Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004; 22: 2489–503
Wang Z, Gorski JC, Hamman MA, et al. The effects of St John’s wort (Hyperionm perforation) on human cytochrome P450 activity. Clin Pharmacol Ther 2001; 70: 317–26
Wang Z, Hamman MA, Huang S-M, et al. Effect of St John’s wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 71: 414–20
Hennessy M, Kelleher D, Spiers JP, et al. St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 2002; 53: 75–82
Dürr D, Stieger B, Kullak-Ublick GA, et al. St John’s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000; 68: 598–4
Moore LB, Goodwin B, Jones SA, et al. St John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 2000; 97: 7500–2
Choudhuri S, Valerio LG. Usefulness of studies on the molecular mechanism of action of herbals/botanicals: the case of St John’s wort. J Biochem Mol Toxicol 2005; 19: 1–11
Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St John’s wort. Lancet 2000; 355: 547–8
Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John’s wort [letter]. Lancet 2000; 355: 548–9
Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John’s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003; 290: 1500–4
Barone GW, Gurley BJ, Ketel BL, et al. Drug interaction between St. John’s wort and cyclosporine. Ann Pharmacother 2000; 34: 1013–6
Huang S-M, Lesko LJ. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol 2004; 44: 559–69
Raucy JL. Regulation of CYP3A4 expression in human hepatocytes by Pharmaceuticals and natural products. Drug Metab Dispos 2003; 31: 533–9
Gorski JC, Huang S-M, Zaheer N, et al. The effect of echinacea on CYP3A activity in vivo. Clin Pharmacol Ther 2004; 75: 89–100
Valentova K, Ulrichova J. Smallanthus sonchifolius and Lepidium meyenii: prospective Andean crops for the prevention of chronic diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147: 119–30
Malini T, Vanithakumari G. Antifertility effects of beta-sitosterol in male albino rats. J Ethnopharmacol 1991; 35: 149–53
Acknowledgements
The authors thank Dr Ronald F. Chanderbhan for his helpful comments of this manuscript. No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
The opinions and conclusions expressed in this article are solely the views of the author and do not necessarily reflect those of the U.S. Food and Drug Administration
Rights and permissions
About this article
Cite this article
Valerio, L.G., Gonzales, G.F. Toxicological Aspects of the South American Herbs Cat’s Claw (Uncaria tomentosa) and Maca (Lepidium meyenii). Toxicol Rev 24, 11–35 (2005). https://doi.org/10.2165/00139709-200524010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00139709-200524010-00002